Why Heron Therapeutics Stock Jumped Today
Shares of Heron Therapeutics (NASDAQ: HRTX) were jumping 7.3% as of 3:08 p.m. EDT on Monday after rising as much as 13% earlier in the day. The gain came after the drugmaker provided its first-quarter update Monday morning.
Heron announced Q1 revenue of $20 million, down 21% year over year. It reported a net loss of $52.6 million, or $0.58 per share. The average analysts' estimate projected Q1 revenue of $25.7 million and a loss of $0.57 per share.
Image source: Getty Images.
Source Fool.com
